Marshall Wace
ZURA icon

Marshall Wace’s Zura Bio ZURA Stock Holding History

Marshall Wace’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.07M Sell
852,340
-25,423
-3% -$154K 0.01% 1298
2025
Q4 		$4.6M Buy
877,763
+610,563
+229% +$2.41M ﹤0.01% 1193
2025
Q3 		$1.16M Buy
+267,200
New +$481K ﹤0.01% 1877
2023
Q1 		– Sell
-486,402
Closed -$4.97M – 3172
2022
Q4 		$4.97M Hold
486,402
– – 0.01% 1192
2022
Q3 		$4.89M Hold
486,402
– – 0.01% 1385
2022
Q2 		$4.84M Hold
486,402
– – 0.01% 1367
2022
Q1 		$4.82M Buy
486,402
+204,882
+73% +$2.02M 0.01% 1403
2021
Q4 		$2.78M Buy
+281,520
New +$2.78M 0.01% 1830

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace's ZURA Position: Q1 2026 in Review

Marshall Wace reduced its Zura Bio (ZURA) stake by 2.9% in Q1 2026, selling an estimated $154K and leaving 852,340 shares worth $5.07M. The position accounts for 0.01% of the portfolio, ranked #1298.

Marshall Wace first reported a position in ZURA in Q4 2021 and has held it in 8 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Marshall Wace held 852,340 shares of Zura Bio worth $5.07M as of Q1 2026.
  • Marshall Wace sold 25,423 Zura Bio shares in Q1 2026, an estimated $154K.
  • Zura Bio made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1298 holding.
  • Marshall Wace first reported a position in Zura Bio in Q4 2021 and has held it in 8 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.